Herpes simplex virus ocular disease

Herpes Simplex Viruses

Volumn , Issue , 2017, Pages 239-273

  Liesegang, Thomas J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890663900     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203711828     Document Type: Chapter

References (133)

1. Pavan-Langston D. Herpes simplex of the ocular anterior segment. Curr Clin Top Infect Dis 2000; 20:298-324.
2. Claoue C, Hill T, Blyth W, Easty D. Clinical findings after zosteriform spread of herpes simplex virus to the eye of the mouse. Curr Eye Res 1987; 6:281-286.
3. Grau DR, Visalli RJ, Brandt CR. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence. Invest Ophthalmol Vis Sci 1989; 30:2474-2480.
4. Stulting RD, Kindle JC, Nahmias AJ. Patterns of herpes simplex keratitis in inbred mice. Invest Ophthalmol Vis Sci 1985; 26:1360-1367.
5. Wander AH, Centifanto YM, Kaufman HE. Strain specificity of clinical isolates of herpes simplex virus. Arch Ophthalmol 1980; 98:1458-1461.
6. Centifanto-Fitzgerald YM, Fenger T, Kaufman HE. Virus proteins in herpetic keratitis. Exp Eye Res 1982; 35:425-441.
7. Tullo AB, Coupes D, Klapper P, Cleator G, Chitkara D. Analysis of glycoproteins expressed by isolates of herpes simplex virus causing different forms of keratitis in man. Curr Eye Res 1987; 6:33-38.
8. Yeung KC, Oakes JE, Lausch RN. Differences in the capacity of two herpes simplex virus isolates to spread from eye to brain map to 1610 base pairs of DNA found in the gene for DNA polymerase. Curr Eye Res 1991; 10: 31-37.
9. Day SP, Lausch RN, Oakes JE. Nucleotide sequences important in DNA replication are responsible for differences in the capacity of two herpes simplex virus strains to spread from cornea to central nervous system. Curr Eye Res 1987; 6:19-26.
10. Hill JM, Rayfield MA, Haruta Y. Strain specificity of spontaneous and adre-nergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res 1987; 6:91-97.
11. Remeijer L, Maertzdorf J, Buitenwerf J, Osterhaus AD, Verjans GM. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci 2002; 43:358-363.
12. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 1997; 18:443-149.
13. Hendricks RL. An immunologist’s view of herpes simplex keratitis: Thygeson Lecture 1996, presented at the Ocular Microbiology and Immunology Group meeting, October 26, 1996. Cornea 1997; 16:503-506.
14. Miller JK, Laycock KA, Nash MM, Pepose JS. Corneal Langerhans cell dynamics after herpes simplex virus reactivation. Invest Ophthalmol Vis Sci 1993; 34:2282-2290.
15. Boorstein SM, Elner SG, Meyer RF, Sugar A, Strieter RM, Kunkel SL, Elner VM. Interleukin-10 inhibition of HLA-DR expression in human herpes stromal keratitis. Ophthalmology 1994; 101:1529-1535.
16. Deshpande SP, Lee S, Zheng M, Song B, Knipe D, Kapp JA, Rouse BT. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J Virol 2001; 75:3077-3088.
17. Brik D, Dunkel E, Pavan-Langston D. Herpetic keratitis: persistence of viral particles despite topical and systemic antiviral therapy. Report of two cases and review of the literature. Arch Ophthalmol 1993; 111:522-527.
18. Missotten L. Immunology and herpetic keratitis. Eye 1994; 8:12-21.
19. Pepose JS. Herpes simplex keratitis: role of viral infection versus immune response. Surv Ophthalmol 1991; 35:345-352.
20. Dawson C, Togni B, Moore TE Jr. Structural changes in chronic herpetic keratitis. Studied by light and electron microscopy. Arch Ophthalmol 1968; 79:740-747.
21. Metcalf JF, Kaufman HE. Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. Am J Ophthalmol 1976; 82:827-834.
22. Kobayashi S, Shogi K, Ishizu M. Electron microscopic demonstration of viral particles in keratitis. Jpn J Ophthalmol 1972; 16:247-250.
23. Ahonen R, Vannas A, Makitie J. Virus particles and leukocytes in herpes simplex keratitis. Cornea 1984; 3:43-50.
24. Alvarado JA, Underwood JL, Green WR, Wu S, Murphy CG, Hwang DG, Moore TE, O’Day D. Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol 1994; 112:1601-1609.
25. Easty DL. Pathogenesis of herpes simplex stromal keratitis: role of replicating virus. In: Cavanagh HD, ed. The Cornea: Transactions of the World Congress on the Cornea III. New York: Raven Press, 1988.
26. Holbach LM, Font RL, Naumann GO. Herpes simplex stromal and endothelial keratitis. Granulomatous cell reactions at the level of Descemet’s membrane, the stroma, and Bowman’s layer. Ophthalmology 1990; 97:722-728.
27. Liesegang TJ. Ocular herpes simplex infection: pathogenesis and current therapy. Mayo Clin Proc 1988; 63:1092-1105.
28. Vannas A, Ahonen R, Makitie J. Corneal endothelium in herpetic keratouvei-tis. Arch Ophthalmol 1983; 101:913-915.
29. Kaufman HE, Kanai A, Ellison ED. Herpetic iritis: demonstration of virus in the anterior chamber by fluorescent antibody techniques and electron microscopy. Am J Ophthalmol 1971; 71:465-169.
30. Sundmacher R, Neumann-Haefelin D. Herpes simplex virus isolations from the aqueous humor of patients suffering from focal iritis, endotheliitis, and prolonged disciform keratitis with glaucoma. Klin Monatsbl Augenheilkd 1979; 175:488-501.
31. Olsen TW, Hardten DR, Meiusi RS, Holland EJ. Linear endotheliitis. Am J Ophthalmol 1994; 117:468-474.
32. Vannas A, Ahonen R. Herpetic endothelial keratitis. A case report. Acta Ophthalmol (Copenh) 1981; 59:296-301.
33. Robin JB, Steigner JB, Kaufman HE. Progressive herpetic corneal endotheliitis. Am J Ophthalmol 1985; 100:336-337.
34. Oh JO. Endothelial lesions of rabbit cornea produced by herpes simplex vims. Invest Ophthalmol 1970; 9:196-205.
35. Ohashi Y, Yamamoto S, Nishida K, Okamoto S, Kinoshita S, Hayashi K, Manabe R. Demonstration of herpes simplex virus DNA in idiopathic corneal endotheliopathy. Am J Ophthalmol 1991; 112:419-123.
36. Sundmacher R, Neumann-Haefelin D. Herpes simplex virus-positive and negative keratouveitis. In: Silverstein AM, O’Connor GR, eds. Immunology and Immunopathology of the Eye. New York: Masson Publishing USA, 1979:225-229.
37. Meyers RL, Chitjian PA. Immunology of herpesvirus infection: immunity to herpes simplex virus in eye infections. Surv Ophthalmol 1976; 21:194-204.
38. Mitchell SM, Phylactou L, Fox JD, Kilpatrick MW, Murray PI. The detection of herpesviral DNA in aqueous fluid samples from patients with Fuchs’ het-erochromic cyclitis. Ocul Immunol Inflamm 1996; 4:33-38.
39. Sundmacher R. A clinico-virologic classification of herpetic anterior segment diseases with special reference to intraocular herpes. In: Sundmacher R, ed. Herpetic Eye Diseases. Munich: JF Bergmann Verlag, 1981:203-210.
40. Witmer R, Iwamoto T. Electron microscope observation of herpes-like particles in the iris. Arch Ophthalmol 1968; 79:331-337.
41. Ahonen R, Vannas A. Clinical comparison between herpes simplex and herpes zoster ocular infections. In: Maudgal PC, Missotten L, eds. Herpetic Eye Diseases. The Netherlands: Dr. W. Junk Publishers, 1985.
42. Collin HB, Abelson MB. Herpes simplex virus in human cornea, retrocorneal fibrous membrane, and vitreous. Arch Ophthalmol 1976; 94:1726-1729.
43. Pavan-Langston D, Brockhurst RJ. Herpes simplex panuveitis. A clinical report. Arch Ophthalmol 1969; 81:783-787.
44. Gordon YJ. Pathogenesis and latency of herpes simplex virus type 1 (HSV-1): an ophthalmologist’s view of the eye as a model for the study of the virus-host relationship. Adv Exp Med Biol 1990; 278:205-209.
45. Gordon YJ, McKnight JL, Ostrove JM, Romanowski E, Araullo-Cruz T. Host species and strain differences affect the ability of an HSV-1 ICPO deletion mutant to establish latency and spontaneously reactivate in vivo. Virology 1990; 178:469-477.
46. Kaufman HE, Brown DC, Ellison EM. Recurrent herpes in the rabbit and man. Science 1967; 156:1628-1629.
47. Kaye SB, Madan N, Dowd TC, Hart CA, McCarthy K, Patterson A. Ocular shedding of herpes simplex virus. Br J Ophthalmol 1990; 74:114-116.
48. Cook SD, Hill JH. Herpes simplex virus: molecular biology and the possibility of corneal latency. Surv Ophthalmol 1991; 36:140-148.
49. Gordon YJ, Romanowski E, Araullo-Cruz T, McKnight JL. HSV-1 corneal latency [letter]. Invest Ophthalmol Vis Sci 1991; 32:663-665.
50. Perng GC, Zwaagstra JC, Ghiasi H, Kaiwar R, Brown DJ, Nesburn AB, Wechsler SL. Similarities in regulation of the HSV-1 LAT promoter in corneal and neuronal cells. Invest Ophthalmol Vis Sci 1994; 35:2981-2989.
51. Liesegang TJ. Biology and molecular aspects of herpes simplex and varicella-zoster virus infections. Ophthalmology 1992; 99:781-799.
52. Easty DL, Shimeld C, Claoue CM, Menage M. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr Eye Res 1987; 6:69-74.
53. Tullo AB, Easty DL, Shimeld C, Stirling PE, Darville JM. Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis. Trans Ophthalmol Soc UK 1985; 104:159-165.
54. Laycock KA, Lee SF, Stulting RD, Croen KD, Ostrove JM, Straus SE, Pepose JS. Herpes simplex virus type 1 transcription is not detectable in quiescent human stromal keratitis by in situ hybridization. Invest Ophthalmol Vis Sci 1993; 34:285-292.
55. Cleator GM, Klapper PE, Dennett C, Sullivan AL, Bonshek RE, Marcyniuk B, Tullo AB. Corneal donor infection by herpes simplex virus: herpes simplex virus DNA in donor corneas. Cornea 1994; 13:294-304.
56. Cockerham GC, Krafft AE, McLean IW. Herpes simplex virus in primary graft failure. Arch Ophthalmol 1997; 115:586-589.
57. Chang TS, Brewer LV, Hooper PL. Primary herpes simplex iridocyclitis with iris atrophy [letter]. Arch Ophthalmol 1993; 111:25-26.
58. Herpetic Eye Disease Study Group. Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Arch Ophthalmol 2000; 118:1617-1625.
59. Wilhelmus KR. Epidemiology of ocular infections. In: Baum J, Liesegang TJ, eds. Duane’s Foundations of Clinical Ophthalmology. Vol. 2. Philadelphia: Lippincott Williams & Wilkins, 1998:1-16.
60. Dhaliwal DK, Barnhorst DA Jr., Romanowski E, Rehkopf PG, Gordon YJ. Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model. Am J Ophthalmol 1998; 125:488-492.
61. Liesegang TJ, Melton LJ III, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simple. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989; 107:1155-1159.
62. Liesegang TJ. Epidemiology of ocular herpes simple. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989; 107:1160-1165.
63. Laibson PR, Leopald IH. An evaluation of double blind IDU therapy in 100 cases of herpetic keratitis. Ophthalmology 1964; 68:22-34.
64. Darougar S, Hunter PA, Viswalingam M, Gibson JA, Jones BR. Acute follicular conjunctivitis and keratoconjunctivitis due to herpes simplex virus in London. Br J Ophthalmol 1978; 62:843-849.
65. Wishart PK, James C, Wishart MS, Darougar S. Prevalence of acute conjunctivitis caused by chlamydia, adenovirus, and herpes simplex virus in an ophthalmic casualty department. Br J Ophthalmol 1984; 68:653-655.
66. Wishart MS, Darougar S, Viswalingam ND. Recurrent herpes simplex virus ocular infection: epidemiological and clinical features. Br J Ophthalmol 1987; 71:669-672.
67. Wilhelmus KR, Falcon MG, Jones BR. Bilateral herpetic keratitis. Br J Ophthalmol 1981; 65:385-387.
68. Herpetic Eye Disease Study Group. Predictors of recurrent herpes simplex virus keratitis. Cornea 2001; 20:123-128.
69. Ribaric V. The incidence of herpetic keratitis among population. Ophthalmo-logica 1976; 173:19-22.
70. Norn MS. Dendritic (herpetic) keratitis. I. Incidence-seasonal variations-recurrence rate-visual impairment-therapy. Acta Ophthalmol 1970; 48: 91-107.
71. Mortensen KK, Sjolie AK. Keratitis dendritica. An epidemiological investigation. Acta Ophthalmol (Copenh) 1979; 57:750-754.
72. Remeijer L, Doornenbal P, Geerards AJ, Rijneveld WA, Beekhuis WH. Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. Ophthalmology 1997; 104:648-652.
73. Neumann-Haefelin D, Sundmacher R, Wochnik G, Bablok B. Herpes simplex virus types 1 and 2 in ocular disease. Arch Ophthalmol 1978; 96:64-69.
74. Rosenwasser GO, Greene WH. Simultaneous herpes simplex types 1 and 2 keratitis in acquired immunodeficiency syndrome. Am J Ophthalmol 1992; 113:102-103.
75. Robinson MJ, Newton C. Bilateral herpes simplex keratitis in a patient with graft-vs-host disease. Am J Ophthalmol 1991; 112:468-469.
76. Margolis TP, Ostler HB. Treatment of ocular disease in eczema herpeticum. Am J Ophthalmol 1990; 110:274-279.
77. Wilhelmus KR, Coster DJ, Donovan HC, Falcon MG, Jones BR. Prognosis indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration. Arch Ophthalmol 1981; 99:1578-1582.
78. Uchio E, Hatano H, Mitsui K, Sugita M, Okada K, Goto K, Kagiya M, Enomoto Y, Ohno S. A retrospective study of herpes simplex keratitis over the last 30 years. Jpn J Ophthalmol 1994; 38:196-201.
79. Gamus D, Romano A, Sucher E, Ashkenazi IE. Herpetic eye attacks: variability of circannual rhythms. Br J Ophthalmol 1995; 79:50-53.
80. Bell DM, Holman RC, Pavan-Langston D. Herpes simplex keratitis: epidemiologic aspects. Ann Ophthalmol 1982; 14:421-122, 424.
81. Holland EJ, Mahanti RL, Belongia EA, Mizener MW, Goodman JL, Andres CW, Osterholm MT. Ocular involvement in an outbreak of herpes gladiatorum. Am J Ophthalmol 1992; 114:680-684.
82. Nasisse MP, Guy JS, Davidson MG, Sussman WA, Fairley NM. Experimental ocular herpesvirus infection in the cat. Sites of virus replication, clinical features and effects of corticosteroid administration. Invest Ophthalmol Vis Sci 1989; 30:1758-1768.
83. Wilhelmus KR, Coster DJ, Jones BR. Acyclovir and debridement in the treatment of ulcerative herpetic keratitis. Am J Ophthalmol 1981; 91:323-327.
84. Darougar S, Wishart MS, Viswalingam ND. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol 1985; 69:2-6.
85. McGill J, Tormey P, Walker CB. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br J Ophthalmol 1981; 65:610-613.
86. Collum LM, O’Connor M, Logan P. Comparison of the efficacy and toxicity of acyclovir and of adenine arabinoside when combined with dilute betamethasone in herpetic disciform keratitis: preliminary results of a double-blind trial. Trans Ophthalmol Soc UK 1983; 103:597-599.
87. Schwab IR. Oral acyclovir in the management of herpes simplex ocular infections. Ophthalmology 1988; 95:423-430.
88. van der Meer JW, Versteeg J. Acyclovir in severe herpes virus infections. Am J Med 1982; 73:271-274.
89. Bialasiewicz AA, Jahn GJ. Systemic acyclovir therapy in recurrent keratouvei-tis caused by herpes simplex virus. Klin Monatsbl Augenheilkd 1984; 185:539.
90. Sundmacher R. Oral acyclovir therapy of virologically proven intraocular herpes simplex virus infections. Klin Monatsbl Augenheilkd 1983; 183: 246-250.
91. Barron BA, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Wilhelmus KR, Kaufman HE, Sugar J, Hyndiuk RA. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994; 101:1871-1882.
92. Collum LM, Logan P, Ravenscroft T. Acyclovir (Zovirax) in herpetic disciform keratitis. Br J Ophthalmol 1983; 67:115-118.
93. Colin J, Mazet D, Chastel C. Treatment of herpetic keratouveitis: comparative action of vidarabine, trifluorothymidine and acyclovir in combination with corticoids. In: Maudgal PC, Missotten L, eds. Herpetic Eye Diseases: Proceedings of the International Symposium. Dordrecht: Dr. W. Junk, 1985:227-232.
94. Sanitato JJ, Asbell PA, Varnell ED, Kissling GE, Kaufman HE. Acyclovir in the treatment of herpetic stromal disease. Am J Ophthalmol 1984; 98:537-547.
95. Shimeld C, Tullo AB, Easty DL, Thomsitt J. Isolation of herpes simplex virus from the cornea in chronic stromal keratitis. Br J Ophthalmol 1982; 66: 643-647.
96. Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Barron BA, Kaufman HE, Sugar J, Hyndiuk RA. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994; 101:1883-1896.
97. Wilhelmus KR. Diagnosis and management of herpes simplex stromal keratitis. Cornea 1987; 6:286-291.
98. Cantin E, Chen J, Willey DE, Taylor JL, O’Brien WJ. Persistence of herpes simplex virus DNA in rabbit corneal cells. Invest Ophthalmol Vis Sci 1992; 33: 2470-2475.
99. Kaye SB, Lynas C, Patterson A, Risk JM, McCarthy K, Hart CA. Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol 1991; 75:195-200.
100. Thompson WS, Culbertson WW, Smiddy WE, Robertson JE, Rosenbaum JT. Acute retinal necrosis caused by reactivation of herpes simplex virus type 2. Am J Ophthalmol 1994; 118:205-211.
101. Ganatra JB, Chandler D, Santos C, Kuppermann B, Margolis TP. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol 2000; 129:166-172.
102. Batisse D, Eliaszewicz M, Zazoun L, Baudrimont M, Pialoux G, Dupont B. Acute retinal necrosis in the course of AIDS: study of 26 cases. AIDS 1996; 10:55-60.
103. Duker JS, Nielsen JC, Eagle RC Jr, Bosley TM, Granadier R, Benson WE. Rapidly progressive acute retinal necrosis secondary to herpes simplex virus, type 1. Ophthalmology 1990; 97:1638-1643.
104. Sidikaro Y, Silver L, Holland GN, Kreiger AE. Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. Ophthalmology 1991; 98:129-135.
105. Yamamoto S, Pavan-Langston D, Tada R, Yamamoto R, Kinoshita S, Nishida K, Shimomura Y, Tano Y. Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol 1995; 119:796-798.
106. Sutcliffe E, Baum J. Acute idiopathic corneal endotheliitis. Ophthalmology 1984; 91:1161-1165.
107. Ohashi Y, Kinoshita S, Mano T, Kiritoshi A, Ohji M. Idiopathic corneal endotheliopathy. A report of two cases. Arch Ophthalmol 1985; 103: 1666-1668.
108. Hakm KN, Dart JK, Sherrard E. Sporadic diffuse corneal endotheliitis. Am J Ophthalmol 1989; 108:509-515.
109. Sugar A, Smith T. Presumed autoimmune corneal endotheliopathy. Am J Ophthalmol 1982; 94:689-691.
110. Holbach LM, Asano N, Naumann GO. Infection of the corneal endothelium in herpes simplex keratitis. Am J Ophthalmol 1998; 126:592-594.
111. Reynolds JD, Griebel M, Mallory S, Steele R. Congenital herpes simplex retinitis. Am J Ophthalmol 1986; 102:33-36.
112. Cibis GW, Flynn JT, Davis EB. Herpes simplex retinitis. Arch Ophthalmol 1978; 96:299-302.
113. Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford CA. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980; 66:489-194.
114. Nahmias AJ, Visintine AM, Caldwell DR, Wilson LA. Eye infections with herpes simplex viruses in neonates. Surv Ophthalmol 1976; 21:100-105.
115. Beigi B, Algawi K, Foley-Nolan A, O’Keefe M. Herpes simplex keratitis in children. Br J Ophthalmol 1994; 78:458-160.
116. Poirier RH. Herpetic ocular infections of childhood. Arch Ophthalmol 1980; 98:704-706.
117. Johnson LS, Polsky B. Herpes simplex virus infection in the cancer patient. Infect Med 1993; 10:18-52.
118. Safrin S. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS. J Acquir Immune Dene Syndr 1992; 5:S29-S32.
119. Stewart JA, Reef SE, Pellett PE, Corey L, Whitley RJ. Herpes virus infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(suppl 1):S114-S120.
120. Young TL, Robin JB, Holland GN, Hendricks RL, Paschal JF, Engstrom RE Jr, Sugar J. Herpes simplex keratitis in patients with acquired immune deficiency syndrome. Ophthalmology 1989; 96:1476-1479.
121. Pavan-Langston D. Herpetic infections. In: Smolin G, Thoft RA, eds. The Cornea. Boston: Little Brown, 1994.
122. Kowalski RP, Gordon YJ. Evaluation of immonologic tests for the detection of ocular herpes simplex virus. Ophthalmology 1989; 9:1583-1586.
123. Gaynor BD, Margolis TP, Cunningham ET Jr. Advances in diagnosis and management of herpetic uveitis. Int Ophthalmol Clin 2000; 40:85-109.
124. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998; 339:300-306.
125. The Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis trial. Arch Ophthalmol 1997; 115:703-712.
126. The Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch Ophthalmol 1996; 114: 1065-1072.
127. The Herpetic Eye Disease Study Group. Oral acyclovir for herpes simplex virus eye disease: effect of prevention of epithelial keratitis and stromal keratitis. Arch Ophthalmol 2000; 118:1030-1036.
128. Simon AL, Pavan-Langston D. Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology 1996; 103:1399-1404; discussion 1404-1405.
129. Barney NP, Foster CS. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 1994; 13: 232-236.
130. Cook SD. Herpes simplex virus in the eye. Br J Ophthalmol 1992; 76:365-366.
131. Cobo LM, Coster DJ, Rice NS, Jones BR. Prognosis and management of corneal transplantation for herpetic keratitis. Arch Ophthalmol 1980; 98: 1755-1759.
132. The Australian Corneal Graft Registry. 1990 to 1992 report. Aust N Z J Ophthalmol 1993; 21:1-48.
133. Shimomura Y. Herpes simplex virus latency in the cornea. In: Kinoshita S, Ohashi Y, eds. Current Opinions in the Kyoto Cornea Club Vol. II. New York: Kugler Publications, 1998:63-67.